Redefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience Partnership
Backed predominantly by surgeon investors, Redefine has raised $10 million to advance its surgical intelligence platform toward commercialization.
Catalyst OrthoScience joins as its Founding Partner in developing surgica
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.